Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Gilles A. Salles"'
Autor:
Richard J. Lin, Colette N. Owens, Esther Drill, Augustine Iannotta, Mayan Oliveros, Dylan L. Schick, Ariela Noy, John F. Gerecitano, Pamela R. Drullinsky, Philip C. Caron, Anita Kumar, Matthew J. Matasar, Craig Moskowitz, Beatriz Korc-Grodzicki, Andrew D. Zelenetz, Gilles A. Salles, Paul A. Hamlin
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Diffuse large B-cell lymphoma (DLBCL) predominantly affects older adults with suboptimal therapeutic outcomes due to increased treatment-related mortality and toxicities in vulnerable patients, clinically defined by geriatric impairments such as func
Externí odkaz:
https://doaj.org/article/addc2a88dd6f4f718d5313e1a1df2a7a
Autor:
Jean-Philippe Jais, Thierry Jo Molina, Philippe Ruminy, David Gentien, Cecile Reyes, David W. Scott, Lisa M. Rimsza, George Wright, Randy D. Gascoyne, Louis M. Staudt, Corinne Haioun, Herve Tilly, Philippe Gaulard, Gilles A. Salles, Fabrice Jardin, Karen Leroy
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
Externí odkaz:
https://doaj.org/article/50d0dacdabdd4c9b97f8fa731a844f2a
Autor:
Lars P. Jordheim, Vincent Ribrag, Hervé Ghesquieres, Sophie Pallardy, Richard Delarue, Hervé Tilly, Corinne Haioun, Fabrice Jardin, Delphine Demangel, Gilles A. Salles, Charles Dumontet
Publikováno v:
Haematologica, Vol 100, Iss 5 (2015)
Externí odkaz:
https://doaj.org/article/edc4a4a63ddc4facba1b13ce34caae5c
Publikováno v:
Blood. 141:467-480
Treatment paradigms for B-cell non-Hodgkin lymphomas (B-NHL) have shifted dramatically in the last 2 decades following the introduction of highly active immunotherapies such as rituximab. Since then, the field has continued to witness tremendous prog
Autor:
Ana Alarcon Tomas, Joshua A. Fein, Shalev Fried, Jessica R. Flynn, Sean M. Devlin, Warren B. Fingrut, Theodora Anagnostou, Anna Alperovich, Nishi Shah, Ellen Fraint, Richard J. Lin, Michael Scordo, Connie Lee Batlevi, Michal J. Besser, Parastoo B. Dahi, Ivetta Danylesko, Sergio Giralt, Brandon S. Imber, Elad Jacoby, Meirav Kedmi, Arnon Nagler, M. Lia Palomba, Mikhail Roshal, Gilles A. Salles, Craig Sauter, Noga Shem-Tov, Avichai Shimoni, Joachim Yahalom, Ronit Yerushalmi, Gunjan L. Shah, Abraham Avigdor, Miguel-Angel Perales, Roni Shouval
Publikováno v:
Leukemia
Persistence or recurrence of large B-cell lymphoma after CD19-CAR-T is common, yet data guiding management are limited. We describe outcomes and features following CAR-T treatment failure. Of 305 adults who received CD19-CAR-T, 182 experienced diseas
Autor:
Richard J. Lin, Soo Jung Kim, Samantha Brown, Theresa A Elko, Josel D Ruiz, Danielle M. Hanley, M. Lia Palomba, Miguel-Angel Perales, Gunjan L. Shah, Parastoo B. Dahi, Michael Scordo, Craig S Sauter, Connie Lee Batlevi, Ana Alarcon Tomas, Roni Shouval, Nicole Lee, Emma A Pavkovic, Danielle E. Engstler, Jae H. Park, Gilles A. Salles, Sean M. Devlin, Beatriz Korc-Grodzicki, Paul A. Hamlin, Sergio A. Giralt
Publikováno v:
Blood Advances.
Autor:
William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J. Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E Lewis, Andrew D Zelenetz, M. Lia Palomba, Matthew J Matasar, Ariela Noy, Audrey M Hamilton, Paul A. Hamlin, Philip C Caron, David J Straus, Andrew M Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N Owens, Craig S Sauter, Lorenzo Falchi, Jennifer K Lue, Santosha A Vardhana, Gilles A. Salles, Ahmet Dogan, Nikolaus D Schultz, Maria E Arcila, Steven M Horwitz
Publikováno v:
Blood Advances.
Nodal peripheral T-cell lymphomas (PTCL), the most common PTCLs, are generally treated with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)-based curative-intent chemotherapy. Recent molecular data have assisted in prognosticating these
Autor:
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. LaCasce, Georg Lenz, José I. Martin-Subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott
Publikováno v:
de Leval, L, Alizadeh, A A, Bergsagel, P L, Campo, E, Davies, A, Dogan, A, Fitzgibbon, J, Horwitz, S M, Melnick, A M, Morice, W G, Morin, R D, Nadel, B, Pileri, S A, Rosenquist, R, Rossi, D, Salaverria, I, Steidl, C, Treon, S P, Zelenetz, A D, Advani, R H, Allen, C E, Ansell, S M, Chan, W C, Cook, J R, Cook, L B, d'Amore, F, Dirnhofer, S, Dreyling, M, Dunleavy, K, Feldman, A L, Fend, F, Gaulard, P, Ghia, P, Gribben, J G, Hermine, O, Hodson, D J, Hsi, E D, Inghirami, G, Jaffe, E S, Karube, K, Kataoka, K, Klapper, W, Kim, W S, King, R L, Ko, Y H, LaCasce, A S, Lenz, G, Martin-Subero, J I, Piris, M A, Pittaluga, S, Pasqualucci, L, Quintanilla-Martinez, L, Rodig, S J, Rosenwald, A, Salles, G A, San-Miguel, J, Savage, K J, Sehn, L H, Semenzato, G, Staudt, L M, Swerdlow, S H, Tam, C S, Trotman, J, Vose, J M, Weigert, O, Wilson, W H, Winter, J N, Wu, C J, Zinzani, P L, Zucca, E, Bagg, A & Scott, D W 2022, ' Genomic profiling for clinical decision making in lymphoid neoplasms ', Blood, vol. 140, no. 21, pp. 2193-2227 . https://doi.org/10.1182/blood.2022015854
With the introduction of large-scale molecular profiling methods and high-throughput sequencing technologies, the genomic features of most lymphoid neoplasms have been characterized at an unprecedented scale. Although the principles for the classific
Autor:
Sara E. DiNapoli, Coleman Spence, Erika Gedvilaite, Anita Bowman, Monica Diosdado, Anna Razumova, Dana Tsui, Gilles A. Salles, Connie Batlevi, Gottfried von Keudell, Ryan Ptashkin, Ahmet Zehir, Michael Berger, A Rose Brannon, Ryma Benayed, Maria Arcila
Publikováno v:
Cancer Research. 82:56-56
Next-generation sequencing of cell-free DNA (cfDNA) can be used to noninvasively assess and monitor patients with lymphoma. Here, we describe the preliminary validation of MSK-ACCESS Heme (Memorial Sloan Kettering-Analysis of Circulating cfDNA to Exa
Autor:
Grzegorz S. Nowakowski, Dok Hyun Yoon, Erel Joffe, Pier Luigi Zinzani, Lorenzo Sabatelli, Eva E. Waltl, Carmelita G. Alvero, Georg Hess, Peter A. Riedell, Kibum Kim, Diana Brixner, Gilles A. Salles
Publikováno v:
Journal of Clinical Oncology. 40:7560-7560
7560 Background: Tafasitamab (tafa) + lenalidomide (LEN) demonstrated efficacy in adult patients (pts) with R/R DLBCL ineligible for autologous stem-cell transplant in the pivotal Phase II study L-MIND (NCT02399085) and received accelerated approval